The Variations and Significance of CA19-9, CA72-4 and CEA in Patients with Gastric Cancer Before and After Treatment with Apatinib

doi:10.11748/bjmy.issn.1006-1703.2018.05.017

PDF(3123 KB)

Labeled Immunoassays and Clinical Medicine ›› 2018, Vol. 25 ›› Issue (5) : 657-660. DOI: 10.11748/bjmy.issn.1006-1703.2018.05.017

The Variations and Significance of CA19-9, CA72-4 and CEA in Patients with Gastric Cancer Before and After Treatment with Apatinib

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2018, 25(5): 657-660 https://doi.org/10.11748/bjmy.issn.1006-1703.2018.05.017

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(3123 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Revised	Published
2017-10-18	2017-11-16	2018-05-20
Issue Date
2019-01-31

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS